Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-0294
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancer ; volume:2 ; number:1 ; day:8 ; month:7 ; year:2016 ; pages:1-5 ; date:12.2016
Journal of pharmaceutical health care and sciences ; 2, Heft 1 (8.7.2016), 1-5, 12.2016
- Urheber
-
Kitade, Hironori
- Beteiligte Personen und Organisationen
-
Hiromasa-Yamasaki, Azusa
Hokkoku, Kengo
Mori, Mitsue
Watanabe, Michio
Nakai, Masuo
Yano, Seiji
SpringerLink (Online service)
- DOI
-
10.1186/s40780-016-0050-y
- URN
-
urn:nbn:de:1111-2016071121112
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kitade, Hironori
- Hiromasa-Yamasaki, Azusa
- Hokkoku, Kengo
- Mori, Mitsue
- Watanabe, Michio
- Nakai, Masuo
- Yano, Seiji
- SpringerLink (Online service)
Ähnliche Objekte (12)
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia
Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
Automatically annotating documents with normalized gene lists
The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients
The Conversion of Bovine Abnormal Prothrombin into Prothrombin
A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia
Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
Automatically annotating documents with normalized gene lists
The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients
The Conversion of Bovine Abnormal Prothrombin into Prothrombin
A case of a warfarinized renal cancer patient monitored for prothrombin time-international normalized ratio during methadone introduction
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Warfarin and boceprevir interaction causing subtherapeutic international normalized ratio: a case report
In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia
Frequency of prothrombin time-international normalized ratio monitoring and the long-term prognosis in patients with mechanical valve replacement
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
Automatically annotating documents with normalized gene lists
The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients
The Conversion of Bovine Abnormal Prothrombin into Prothrombin